Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
Chunyi Shen, Zhen Zhang, Yonggui Tian, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Strategies to enhance CAR-T persistence
Yue Liu, Lingna An, Ruihao Huang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Bioactive sulforaphane from cruciferous vegetables: advances in biosynthesis, metabolism, bioavailability, delivery, health benefits, and applications
Yanli Zhang, Wenyuan Zhang, Yaqi Zhao, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-21
Closed Access | Times Cited: 9
Sulforaphane-mediated immune regulation through inhibition of NF-kB and MAPK signaling pathways in human dendritic cells
Ana María Múnera-Rodríguez, Camila Leiva-Castro, Francisco Sobrino, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117056-117056
Open Access | Times Cited: 7
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Adverse clinical outcomes and immunosuppressive microenvironment of RHO-GTPase activation pattern in hepatocellular carcinoma
Qi Yang, Zewei Zhuo, Xinqi Qiu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents
Feng Zhang, Ruiya Jiang, Shishi Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116267-116267
Closed Access | Times Cited: 6
Nature’s Arsenal: Harnessing the Capacity of Phytochemicals to Enhance Immune Checkpoint Inhibitor Therapy of Cancers: An Especial Attention to Brain Malignancies
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 5
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Sulforaphane activates CD8+T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis’
Jinyan Liu, Huanan Chen, Caijuan Guo, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e007983-e007983
Open Access | Times Cited: 3
Conducting bioinformatics analysis to predict sulforaphane-triggered adverse outcome pathways in healthy human cells
Dragica Božić, Katarina Živančević, Katarina Baralić, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114316-114316
Open Access | Times Cited: 7
Ginsenoside Rg1 improves anti-tumor efficacy of adoptive cell therapy by enhancing T cell effector functions
Yue Liu, Lingna An, Chengfei Yang, et al.
Blood Science (2023)
Open Access | Times Cited: 7
18β-glycyrrhetinic acid suppresses Lewis lung cancer growth through protecting immune cells from ferroptosis
Xuan Ma, Zhenou Sun, Hui Chen, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 93, Iss. 6, pp. 575-585
Closed Access | Times Cited: 2
A Presurgical‐Window Intervention Trial of Isothiocyanate‐Rich Broccoli Sprout Extract in Patients with Breast Cancer
Zinian Wang, Chengjian Tu, Rachel Pratt, et al.
Molecular Nutrition & Food Research (2022) Vol. 66, Iss. 12
Open Access | Times Cited: 11
Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19
Shasha Liu, Baiqiao Wang, Tianran Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Phytochemicals in regulating PD‐1/PD‐L1 and immune checkpoint blockade therapy
Qi Zhang, Chenying Yang, Xingsu Gao, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 776-796
Closed Access | Times Cited: 5
Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
Long Chen, Fukun Chen, Huatao Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy
Hanwen Zhang, Tenzin Passang, Sruthi Ravindranathan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer.
Gabrielle E. Kennelley, Tatiana Amaye-Obu, Barbara A. Foster, et al.
PubMed (2023) Vol. 11, Iss. 2, pp. 103-120
Closed Access | Times Cited: 4
Identification of the molecular characteristics associated with microsatellite status of colorectal cancer patients for the clinical application of immunotherapy
Jie Fu, Xiaoxin Jin, Weidong Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumors
Xuan Zhao, Zhen Zhang, Chunli Wen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Posttranslational regulatory mechanism of PD-L1 in cancers and associated opportunities for novel small-molecule therapeutics
Minchen Cai, Mengting Xu, Dianping Yu, et al.
Acta Biochimica et Biophysica Sinica (2024) Vol. 56, Iss. 10, pp. 1415-1424
Open Access
Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming
Yueyu Dai, Yue Liu, Lingna An, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009949-e009949
Open Access
The role of cellular persistence in CAR T cell therapy
Vivien D. Menkhoff, Sophie Bernhard, Stefanos Michaelides, et al.
Elsevier eBooks (2024)
Closed Access
Targeting immunometabolism to improve cancer therapies
Darby J. Ballard, Liqing Wang, Jugal Kishore Das, et al.
Elsevier eBooks (2024), pp. 95-116
Closed Access
Page 1 - Next Page

Scroll to top